Detailed Information on Publication Record
2020
Lactic Acidosis Interferes With Toxicity of Perifosine to Colorectal Cancer Spheroids: Multimodal Imaging Analysis
PAVLATOVSKÁ, Barbora, Markéta MACHÁLKOVÁ, Petra BRISUDOVÁ, Adam PRUŠKA, Karel ŠTĚPKA et. al.Basic information
Original name
Lactic Acidosis Interferes With Toxicity of Perifosine to Colorectal Cancer Spheroids: Multimodal Imaging Analysis
Authors
PAVLATOVSKÁ, Barbora (203 Czech Republic, belonging to the institution), Markéta MACHÁLKOVÁ (203 Czech Republic, belonging to the institution), Petra BRISUDOVÁ (703 Slovakia, belonging to the institution), Adam PRUŠKA, Karel ŠTĚPKA (203 Czech Republic, belonging to the institution), Jan MICHÁLEK (203 Czech Republic, belonging to the institution), Tereza NEČASOVÁ (203 Czech Republic, belonging to the institution), Petr BENEŠ (203 Czech Republic, belonging to the institution), Jan ŠMARDA (203 Czech Republic, belonging to the institution), Jan PREISLER (203 Czech Republic, belonging to the institution), Michal KOZUBEK (203 Czech Republic, belonging to the institution) and Jarmila NAVRÁTILOVÁ (203 Czech Republic, guarantor, belonging to the institution)
Edition
Frontiers in Oncology, Lausanne, Frontiers Media S.A. 2020, 2234-943X
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
10608 Biochemistry and molecular biology
Country of publisher
Switzerland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 6.244
RIV identification code
RIV/00216224:14310/20:00117367
Organization unit
Faculty of Science
UT WoS
000599610600001
Keywords in English
perifosine; Akt kinase; tumor environment; lactic acidosis; alkalization; signal co-registration; mass spectrometry imaging; colorectal cancer
Tags
International impact, Reviewed
Změněno: 14/1/2021 13:37, Mgr. Marie Šípková, DiS.
Abstract
V originále
Colorectal cancer (CRC) is a disease with constantly increasing incidence and highmortality. The treatment efficacy could be curtailed by drug resistance resulting from poordrug penetration into tumor tissue and the tumor-specific microenvironment, such ashypoxia and acidosis. Furthermore, CRC tumors can be exposed to different pHdepending on the position in the intestinal tract. CRC tumors often share upregulationof the Akt signaling pathway. In this study, we investigated the role of external pH in controlof cytotoxicity of perifosine, the Akt signaling pathway inhibitor, to CRC cells using 2D and3D tumor models. In 3D settings, we employed an innovative strategy for simultaneousdetection of spatial drug distribution and biological markers of proliferation/apoptosisusing a combination of mass spectrometry imaging and immunohistochemistry. In 3Dconditions, low and heterogeneous penetration of perifosine into the inner parts of thespheroids was observed. The depth of penetration depended on the treatment durationbut not on the external pH. However, pH alteration in the tumor microenvironment affectedthe distribution of proliferation- and apoptosis-specific markers in the perifosine-treatedspheroid. Accurate co-registration of perifosine distribution and biological response in thesame spheroid section revealed dynamic changes in apoptotic and proliferative markersoccurring not only in the perifosine-exposed cells, but also in the perifosine-free regions.Cytotoxicity of perifosine to both 2D and 3D cultures decreased in an acidic environmentbelow pH 6.7. External pH affects cytotoxicity of the other Akt inhibitor, MK-2206, in asimilar way. Our innovative approach for accurate determination of drug efficiency in 3Dtumor tissue revealed that cytotoxicity of Akt inhibitors to CRC cells is strongly dependenton pH of the tumor microenvironment. Therefore, the effect of pH should be consideredduring the design and pre-clinical/clinical testing of the Akt-targeted cancer therapy.
Links
EF16_013/0001775, research and development project |
| ||
LM2018129, research and development project |
| ||
LQ1601, research and development project |
| ||
MUNI/A/1127/2019, interní kód MU |
| ||
MUNI/G/0974/2016, interní kód MU |
|